AeroVironment’s drone still grounded on Mars
Ingenuity, the helicopter drone developed by Simi Valley-based AeroVironment, has had its first experimental flight on Mars delayed after an error sequence during testing, according to the National Aeronautics and Space Administration. Ingenuity, which landed on Mars on the Perseverance rover in February, was scheduled for its first takeoff on April 11. NASA first rescheduled Read More →
Read More →AeroVironment’s drone launch on Mars delayed
Ingenuity, the helicopter drone developed by Simi Valley-based AeroVironment, has had its first experimental flight on Mars delayed, according to the National Aeronautics and Space Administration. Ingenuity, which landed on Mars on the Perseverance rover in February, was scheduled for its first takeoff on April 11. The flight has been rescheduled to no earlier than Read More →
Read More →
Cure Pharmaceutical navigates CBD acquisition, licensing dispute
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Inogen adds executive VP; co-founder Myers to step down
Inogen, a Goleta-based medical technology company that makes portable oxygen concentrators, announced April 7 that it has hired Georg Parr as executive vice president and chief commercial officer. Byron Myers, a member of Inogen’s founding team and the current executive vice president for marketing, will step down on June 4, as will Arron Retterer, the Read More →
Read More →Inogen’s new CEO looks to the future
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →How to borrow $4 billion: With financing secure, path is nearly clear for Teledyne/Flir deal
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Revenues and losses both grew at Cure in 2020
Cure Pharmaceutical, an Oxnard company with a CBD products subsidiary, reported steep revenue growth but rising net losses in the fourth quarter and full year of 2020. In an annual statement released April 1, Cure reported revenue of $2.1 million in the final quarter of 2020, up 229% from the same quarter a year before. Read More →
Read More →
